年轻浸润性乳腺癌的临床病理特点和治疗预后分析
苏州大学附属第一医院
摘要:目的 研究分析年轻浸润性乳腺癌患者手术方式、临床病理参数及其预后。方法 回顾性收集 2015 年 1 月至 2020 年 5 月我院收治的 169 例年龄≤40 岁浸润性乳腺癌患者资料,按年龄分为≤30 岁组(n=58)和 31~40 岁组(n=111),比较两组临床病理参数及预后。结果 ≤30 岁组 III 期比例更高,T4、N2 占比及肿瘤 增殖细胞核抗原(Ki-67)高表达率均高于 31~40 岁组(P<0.05);该组保乳手术比例较高,改良根治术比例较低(P<0.05)。分子分型中,≤30 岁组 Luminal A 型比例较高,Luminal B 型人表皮生长因子受体 2(HER2)阴性组较低(P<0.05)。5 年随访显示,≤30 岁组复发转移率更高(P<0.05)。结论 年轻浸润性乳腺癌患者肿瘤进展更快、更易转移、Ki-67 高表达多见,预后较差,应尽早诊断和治疗。
Abstract: Objective To investigate and analyze the surgical approaches,clinicopathological parameters and prognosis of young patients with invasive breast cancer. Methods The data of 169 patients with invasive breast cancer aged ≤ 40 years in our hospital from January 2015 to may 2020 were retrospectively collected and divided into ≤ 30 years old group (n=58) and 31~40 years old group (n=111) according to age. Results The proportion of stage III was higher in the ≤ 30-year-old group, and the proportion of T4 and N2 and the high expression rate of proliferating cell nuclear antigen (Ki-67) were higher than those in the 31~40-year-old group (P<0.05). The proportion of breast conserving surgery was higher and the proportion of modified radical surgery was lower in this group (P<0.05). In molecular typing, the proportion of Luminal type A in ≤ 30 years old group was higher, while that in Luminal type B human epidermal growth factor receptor 2 negative group was lower (P<0.05). The 5-year follow-up showed that the recurrence and metastasis rate of ≤ 30 years old group was higher (P<0.05). Conclusion Young patients with invasive breast cancer have faster tumor progression, easier metastasis, high expression of Ki-67 and poor prognosis, which should be diagnosed and treated as soon as possible.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 0 条| 文章编号 | 2025-06-065(期号内编号) |
|---|---|
| 栏目 | 检验与方法 |
| 作者 | 万玉秋 |
| 作者单位 | 苏州大学附属第一医院 |
| 卷期页码 | 2025, (06) |
| 发布时间 | - |
| 出版时间 | - |
| 引用信息 | [1]万玉秋.年轻浸润性乳腺癌的临床病理特点和治疗预后分析[J],2025,01(06):. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-09-22T12:46:29 |